NDC 50742-505

Scopolamine

Scopolamine

Scopolamine is a Transdermal Patch, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Ingenus Pharmaceuticals, Llc. The primary component is Scopolamine.

Product ID50742-505_0b513236-5471-4d8c-bc58-326f674a084b
NDC50742-505
Product TypeHuman Prescription Drug
Proprietary NameScopolamine
Generic NameScopolamine
Dosage FormPatch, Extended Release
Route of AdministrationTRANSDERMAL
Marketing Start Date2020-11-24
Marketing CategoryANDA / ANDA
Application NumberANDA212342
Labeler NameIngenus Pharmaceuticals, LLC
Substance NameSCOPOLAMINE
Active Ingredient Strength2 mg/1
Pharm ClassesAnticholinergic [EPC],Cholinergic Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 50742-505-04

4 POUCH in 1 CARTON (50742-505-04) > 1 PATCH, EXTENDED RELEASE in 1 POUCH
Marketing Start Date2020-11-24
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Scopolamine" or generic name "Scopolamine"

NDCBrand NameGeneric Name
0378-6470Scopolaminescopolamine
0591-2258scopolaminescopolamine
50090-5349Scopolaminescopolamine
50742-505ScopolamineScopolamine
72689-0023KIMITEScopolamine
0067-4345Transderm Scopscopolamine
0067-4346Transderm Scopscopolamine
66758-208Transderm Scopscopolamine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.